Barrett S, Rippon M J, Rogers A A
Humber NHS Foundation Trust, U, Humber NHS Foundation Trust, UK.
Huddersfield University, Huddersfield, UK.
Khirurgiia (Mosk). 2023(2):59-71. doi: 10.17116/hirurgia202302159.
To provide 'in use' clinical data to support exudate management in patients with moderately to highly exuding wounds with bordered superabsorbent wound dressing with a silicone adhesive interface Zetuvit Plus Silicone Border (Paul Hartmann Ltd., Germany).
This study was an open-labelled non-comparative study. Patients included in the study were selected by the clinical investigator(s) according to whether the patient required a dressing for the management of moderately to highly exuding wounds such as pressure ulcers, diabetic foot ulcers, venous leg ulcer and arterial ulcers The patients were treated with A superabsorbent sterile wound dressing with bordered superabsorbent wound dressing with a silicone adhesive interface Zetuvit Plus Silicone Border (Paul Hartmann Ltd., Germany).
The Zetuvit Plus Silicone Border dressing had met the clinical objectives relating to exudate management, affirmed by the health professionals with a yes response in 94% of cases. Additionally, the health professionals rated the handling of exudate as excellent/good (78%) and most (80%) reported that they would use the superabsorbent wound dressing with a silicone adhesive interface again. Allied to this was the fact that the dressing improved the wound edge and periwound skin conditions (29% and 36% of patients, respectively). The dressing retained its position in 72% of patients. For wear time, the largest proportion of dressing changes, both pre-study and during the evaluation period, was every third day (45% and 44%, respectively). But there was a shift to extended wear time with use of the superabsorbent wound dressing with a silicone adhesive interface with 72% of patients' dressing changes being every third day or longer.
The superabsorbent silicone border dressing was successful in managing wound exudate in moderately to highly exuding wounds and consequently this had a beneficial impact on the wound edge and periwound skin. Overall, there was a positive effect on wound bed preparation and in turn the healing response was progressive.
提供“实际使用中”的临床数据,以支持使用带有硅胶粘合剂界面的有边框高吸水性伤口敷料Zetuvit Plus Silicone Border(德国保罗·哈特曼有限公司)对中到高度渗出性伤口患者进行渗液管理。
本研究为开放标签的非对照研究。临床研究者根据患者是否需要使用敷料来处理中到高度渗出性伤口(如压疮、糖尿病足溃疡、下肢静脉溃疡和动脉溃疡)来选择纳入研究的患者。患者使用一种带有硅胶粘合剂界面的有边框高吸水性无菌伤口敷料Zetuvit Plus Silicone Border(德国保罗·哈特曼有限公司)进行治疗。
Zetuvit Plus Silicone Border敷料达到了与渗液管理相关的临床目标,94%的病例中医疗专业人员给出了肯定答复。此外,医疗专业人员将渗液处理评为优秀/良好(78%),并且大多数(80%)报告称他们会再次使用带有硅胶粘合剂界面的高吸水性伤口敷料。与此相关的是,该敷料改善了伤口边缘和伤口周围皮肤状况(分别为29%和36%的患者)。72%的患者敷料保持在位。对于更换敷料的时间,在研究前和评估期间,更换敷料比例最高的都是每三天一次(分别为45%和44%)。但是随着使用带有硅胶粘合剂界面的高吸水性伤口敷料,更换时间有延长的趋势,72%的患者每三天或更长时间更换一次敷料。
带有硅胶边框的高吸水性敷料成功地管理了中到高度渗出性伤口的伤口渗液,因此对伤口边缘和伤口周围皮肤产生了有益影响。总体而言,对伤口床准备有积极作用,进而愈合反应不断进展。